<SEC-DOCUMENT>0001299130-24-000198.txt : 20241213
<SEC-HEADER>0001299130-24-000198.hdr.sgml : 20241213
<ACCEPTANCE-DATETIME>20241213165100
ACCESSION NUMBER:		0001299130-24-000198
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241111
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241213
DATE AS OF CHANGE:		20241213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
		CENTRAL INDEX KEY:			0001299130
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				161590339
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34899
		FILM NUMBER:		241549104

	BUSINESS ADDRESS:	
		STREET 1:		1305 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-521-8000

	MAIL ADDRESS:	
		STREET 1:		1305 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIFIC BIOSCIENCES OF CALIFORNIA INC
		DATE OF NAME CHANGE:	20050829

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOFLUIDICS INC
		DATE OF NAME CHANGE:	20040729
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>pacb-20241111.htm
<DESCRIPTION>8-K/A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:658ad983-a5a7-4729-8248-e8ac8f640e7c,g:ae8b7241-1ef8-4b94-8ae5-be4fdafcd5ca,d:b097e839405447cd94ff4569f7fb443b-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pacb-20241111</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001299130</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-true" id="f-22">true</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentDescription" id="f-23">DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pacb-20241111.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001299130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-11</xbrli:startDate><xbrli:endDate>2024-11-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib097e839405447cd94ff4569f7fb443b_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:0.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K/A</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amendment No. 1</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November&#160;11, 2024</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Pacific Biosciences of California, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-34899</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">16-1590339</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1305 O&#8217;Brien Drive</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Menlo Park</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">94025</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">650</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">521-8000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code) </span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report) </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.840%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">PACB</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib097e839405447cd94ff4569f7fb443b_66"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Explanatory Note</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As previously disclosed on a Form 8-K filed by Pacific Biosciences of California, Inc. (the &#8220;Company&#8221;) on November 12, 2024, the Company notified Jeff Eidel that, in connection with an internal restructuring of the commercial organization, he would separate from his position as the Chief Commercial Officer on November 15, 2024. This Form 8-K/A hereby amends the original Form 8-K filed on November 12, 2024 to supplement the disclosure contained in Item 5.02 thereto and to file the exhibit included as Item 9.01 hereto. Except as provided herein, the disclosures in the Form 8-K filed on November 12, 2024 remain unchanged.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ib097e839405447cd94ff4569f7fb443b_7"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ITEM 5.02.&#160;&#160;&#160;&#160;DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Eidel&#8217;s employment as Chief Commercial Officer concluded on November 15, 2024. On December 6, 2024, the Company and Mr. Eidel entered into a separation agreement and release (the &#8220;Separation Agreement&#8221;), which became effective on December 13, 2024 following a seven-day revocation period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the Separation Agreement, Mr. Eidel will receive (i) a lump of sum of $485,000 (less applicable withholding), which is equivalent to 12 months of current base salary, and (ii) company-paid or company-reimbursed premiums for continuation coverage as applicable, pursuant to COBRA for himself and his dependents (as applicable), for up to 12 months following the separation (together, the &#8220;Severance Benefits&#8221;).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In exchange for the Severance Benefits, Mr. Eidel agreed to release all claims against the Company arising out of or in any way connected with his employment with the Company or his separation from employment, as outlined in the Separation Agreement.  Mr. Eidel also is required to comply with the terms of any confidential information and invention assignment agreement entered into with the Company.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any outstanding vested options to purchase shares of the Company&#8217;s common stock held by Mr. Eidel at the time of his separation must be exercised within three months following the separation or they will become forfeited and terminated.  Any shares subject to restricted stock unit awards or performance-based restricted stock unit awards not yet vested at the time of his separation have been cancelled.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing description of the Separation Agreement is not complete and is subject to and qualified in its entirety by reference to the Separation Agreement, a copy of which is filed with this Current Report on Form 8-K/A as Exhibit 10.1, and the terms of which are incorporated by reference herein.</span></div><div><span><br/></span></div><div id="ib097e839405447cd94ff4569f7fb443b_75"></div><div style="-sec-extract:summary;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.447%"/><td style="width:0.1%"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit101-separationagree.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit101-separationagree.htm">Separation Agreement and Release, dated December 6, 2024 and effective December 13, 2024</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib097e839405447cd94ff4569f7fb443b_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pacific Biosciences of California, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Brett Atkins</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Brett Atkins</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">General Counsel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: December 13, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-separationagree.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ibf41755bf9004d3493561aa41692820e_1"></div><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-left:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="padding-left:86.52pt;padding-right:86.52pt;text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:198px"></div><div style="margin-top:4.6pt"><font><br></font></div><div style="padding-left:0.5pt;padding-right:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SEPARATION AGREEMENT AND RELEASE</font></div><div style="margin-top:11.7pt;padding-left:5pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Separation Agreement and Release (&#8220;Agreement&#8221;) is made by and between Jeff Eidel (&#8220;Employee&#8221;) and Pacific Biosciences of California, Inc. (the &#8220;Company&#8221;) (jointly referred to as the &#8220;Parties&#8221; or individually referred to as a &#8220;Party&#8221;).</font></div><div style="margin-top:12.1pt;padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Employee was employed at-will by the Company&#59;</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Employee signed an At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement with the Company (the &#8220;Confidentiality Agreement&#8221;)&#59;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Company and Employee may have entered into one or more employment-related equity award agreements, which may include stock option agreements granting Employee the option to purchase shares of the Company&#8217;s common stock, or restricted stock unit agreements providing Employee the right to receive restricted stock units covering shares of the Company&#8217;s common stock, in each case subject to the terms and conditions of such agreements (collectively the &#8220;Equity Award Agreements&#8221;)&#59;</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Employee separated from employment with the Company effective November 15, 2024 (the &#8220;Separation Date&#8221;)&#59; and</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that the Employee may have against the Company and any of the Releasees (as defined below), including, but not limited to, any and all claims arising out of or in any way related to Employee&#8217;s employment with or separation from the Company&#59;</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:6.15pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Employee hereby agree as follows&#58;</font></div><div style="margin-top:12.3pt;padding-left:0.55pt;padding-right:0.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COVENANTS</font></div><div style="margin-top:12.4pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In consideration of, and contingent on, (i) Employee&#8217;s execution of this Agreement, (ii) this Agreement going into effect, and (iii) Employee&#8217;s fulfillment of all of its terms and conditions, the Company agrees as follows&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.65pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:12.60pt">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:12.60pt;padding-left:23.42pt;text-decoration:underline">Separation Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:12.60pt">.&#160;&#160;&#160;&#160;The Company agrees to pay Employee a lump sum of $485,000.00, less applicable withholdings. This payment will be made to Employee within thirty (30) business days after the Effective Date of this Agreement.</font></div><div style="margin-top:12.6pt;padding-left:5pt;padding-right:5.65pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">COBRA Premiums</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to Employee timely electing continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;), the Company will pay the premiums required for Employee's and Employee&#8217;s eligible dependents&#8217; continued coverage pursuant to COBRA under the Company's group health plans, until the earliest of&#58; (A) a period of twelve (12) months from December 1, 2024, (B) the date upon which Employee and&#47;or Employee&#8217;s eligible dependents becomes covered under similar plans, or (C) the expiration of Employee&#8217;s and Employee&#8217;s eligible dependents&#8217; (as applicable) eligibility for continuation coverage under COBRA. Notwithstanding the preceding, if the Company determines in its sole discretion that it cannot provide COBRA premium payments without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company will instead provide the Employee a taxable payment in an amount equal to the monthly COBRA premium that the Employee would be required to pay to continue the Employee&#8217;s group health coverage in effect on the date of termination of employment (which amount will be based on the premium for the first month of COBRA</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ibf41755bf9004d3493561aa41692820e_4"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:5pt"><font><br></font></div><div style="padding-left:5pt"><font><br></font></div><div style="padding-left:5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">coverage), which payments will be made regardless of whether the Employee elects COBRA continuation coverage and will commence in the month following the month of the Separation Date and continue for the period of time indicated in this paragraph.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.42pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee acknowledges that without this Agreement, Employee is otherwise not entitled to the consideration listed above. Employee further acknowledges and agrees that this Agreement is a negotiated separation agreement for which consideration does not constitute, in whole or in part, a bonus, raise, employment, or continued employment.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. All equity awards (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, options to purchase shares of Company common stock, restricted stock unit awards, performance share unit awards, etc.), if any, are subject to the terms and conditions of each applicable Equity Award Agreement and the applicable Company equity incentive plan. In general, and subject to any contrary terms of the applicable Equity Award Agreements (which shall control)&#58;</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:6.1pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.42pt">Employee may view the number of available (vested) shares covered by the grant of an option to purchase shares of Company common stock (ISOs or NQs) via Employee&#8217;s Shareworks online account.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt">The vested portion of any outstanding option to purchase shares of Company common stock </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">must be exercised within three (3) months following the Separation Date&#59; any such option not exercised</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">within three (3) months of the Separation Date will be forfeited and terminated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The unvested portion of any option to purchase shares of Company common stock is cancelled at the close of business on the Separation Date.</font></div><div style="margin-top:12.6pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.42pt">Any shares of Company common stock purchased through the Company&#8217;s Employee Stock Purchase Plan (ESPP), and any shares of Company common stock that have vested pursuant to a Restricted Stock Unit (RSU) award or Performance-based Restricted Stock Unit (PSU) award on or prior to the Separation Date, belong to Employee and Employee may sell such shares at any time provided that any such sale must be made in accordance with the Company&#8217;s Insider Trading Policy.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt">Any shares subject to RSU awards or PSU awards that are unvested after the Separation Date are cancelled.</font></div><div style="margin-top:12.6pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.42pt">Upon the Separation Date, contributions credited to Employee&#8217;s ESPP account during an applicable Offering Period under the ESPP but not yet used to purchase shares of Company common stock under the ESPP will be returned to Employee in accordance with the terms of the ESPP.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee&#8217;s Company-sponsored health insurance benefits shall cease no later than the last day of the month in which the Separation Date occurs (or such earlier date as may be required by applicable plan terms and conditions), subject to Employee&#8217;s right to continue Employee&#8217;s health insurance under COBRA. Employee&#8217;s participation in all benefits and incidents of employment, including, but not limited to, vesting in stock options, and the accrual of bonuses, vacation, and paid time off, ceased as of the Separation Date.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Payment of Compensation and Receipt of All Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee acknowledges and represents that, other than the consideration set forth in this Agreement, the Company and its agents have paid or provided (to the extent applicable to Employee) all salary, wages, bonuses, accrued vacation&#47;paid time off, notice periods, premiums, leaves, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, stock options, vesting, and any and all other benefits and compensation due to Employee.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.498%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="padding-left:5pt"><font><br></font></div><div style="margin-top:1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee agrees that the consideration set forth in this Agreement represents settlement in full of all outstanding obligations owed to Employee by the Company, its parents, subsidiaries, and affiliates, and each of their respective current and former officers, directors, employees, agents, investors, attorneys, shareholders, administrators, benefit plans, plan administrators, insurers, trustees, divisions, and predecessor and successor corporations and assigns (collectively, the &#8220;Releasees&#8221;). Employee, on Employee&#8217;s own behalf and on behalf of Employee&#8217;s respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Employee may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the date Employee signs this Agreement, including, without limitation&#58;</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:6pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:23.42pt">any and all claims relating to or arising from Employee&#8217;s employment relationship with the Company and the termination of that relationship&#59;</font></div><div style="margin-top:11.8pt;padding-left:5pt;padding-right:6pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt">any and all claims relating to, or arising from, Employee&#8217;s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law&#59;</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.42pt">any and all claims under the law of any jurisdiction, including, but not limited to, wrongful discharge of employment&#59; constructive discharge from employment&#59; termination in violation of public policy&#59; discrimination&#59; harassment&#59; retaliation&#59; breach of contract, both express and implied&#59; breach of covenant of good faith and fair dealing, both express and implied&#59; promissory estoppel&#59; negligent or intentional infliction of emotional distress&#59; fraud&#59; negligent or intentional misrepresentation&#59; negligent or intentional interference with contract or prospective economic advantage&#59; unfair business practices&#59; defamation&#59; libel&#59; slander&#59; negligence&#59; personal injury&#59; assault&#59; battery&#59; invasion of privacy&#59; false imprisonment&#59; conversion&#59; and disability benefits&#59;</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt">any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, the following, each as may be amended, and except as prohibited by law&#58; Title VII of the Civil Rights Act of 1964&#59; the Civil Rights Act of 1991&#59; the Rehabilitation Act of 1973&#59; the Americans with Disabilities Act of 1990&#59; the Equal Pay Act&#59; the Fair Labor Standards Act&#59; the Fair Credit Reporting Act&#59; the Age Discrimination in Employment Act of 1967&#59; the Older Workers Benefit Protection Act&#59; the Employee Retirement Income Security Act of 1974&#59; the Worker Adjustment and Retraining Notification Act&#59; the Family and Medical Leave Act&#59; the Uniformed Services Employment and Reemployment Rights Act&#59; the Immigration Reform and Control Act&#59; the California Family Rights Act&#59; the California Labor Code&#59; the California Workers&#8217; Compensation Act&#59; the California Worker Adjustment and Retraining Notification Act&#59; and the California Fair Employment and Housing Act&#59;</font></div><div style="margin-top:12pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.37pt">any and all claims for violation of the federal or any state constitution&#59;</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:6.1pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:24.64pt">any and all claims arising out of any other laws and regulations relating to employment or employment discrimination&#59;</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:6.1pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt">any claim for any loss, cost, damage, or expense arising out of any dispute over the nonwithholding or other tax treatment of any of the proceeds received by Employee as a result of this Agreement&#59; and</font></div><div style="margin-top:12.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt">any and all claims for attorneys&#8217; fees and costs.</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.498%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Employee agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released. This release does not extend to any obligations incurred under this Agreement. This release does not release claims that cannot be released as a matter of law. Any and all disputed wage claims that are released herein shall be subject to binding arbitration in accordance with the &#8220;Arbitration&#8221; section below, except as required by applicable law. This release does not extend to any right Employee may have to unemployment compensation benefits. This release does not extend to the Company&#8217;s obligations under the Third-Party Payor Agreement for Legal Services between Ehrlich &#38; Craig LLP and the Company entered into on October 21, 2024.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Acknowledgment of Waiver of Claims under ADEA.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Employee acknowledges that Employee is waiving and releasing any rights Employee may have under the Age Discrimination in Employment Act of 1967 (&#34;ADEA&#34;), and that this waiver and release is knowing and voluntary. Employee agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the date Employee signs this Agreement. Employee acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Employee was already entitled. Employee further acknowledges that Employee has been advised by this writing that&#58; (a) Employee should consult with an attorney </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">prior</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to executing this Agreement&#59; (b) Employee has twenty-one (21) days within which to consider this Agreement&#59; (c) Employee has seven (7) days following Employee&#8217;s execution of this Agreement to revoke this Agreement&#59; (d) this Agreement shall not be effective until after the revocation period has expired&#59; and (e) nothing in this Agreement prevents or precludes Employee from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Employee signs this Agreement and returns it to the Company in less than the 21-day period identified above, Employee hereby acknowledges that Employee has knowingly and voluntarily chosen to waive the time period allotted for considering this Agreement. Employee acknowledges and understands that revocation must be accomplished by a written notification to the person executing this Agreement on the Company&#8217;s behalf that is received prior to the Effective Date. The Parties agree that changes, whether material or immaterial, do not restart the running of the 21-day period.</font></div><div style="margin-top:12.1pt;padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Unknown Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee acknowledges that Employee has been advised to consult with an attorney and is familiar with the following principle, including as set forth in provisions of certain state laws, such as California Civil Code &#167; 1542, which provides as follows&#58;</font></div><div style="margin-top:12pt;padding-left:77pt;padding-right:59.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Employee, being aware of said principle, agrees to expressly waive any rights Employee may have thereunder, as well as under any statute or common law principles of similar effect.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">No Pending or Future Lawsuits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee represents that Employee has no lawsuits, claims, or actions pending in Employee&#8217;s name, or on behalf of any other person or entity, against the Company or any of the other Releasees. Employee also represents that Employee does not currently intend to bring any claims on Employee&#8217;s own behalf or on behalf of any other person or entity against the Company or any of the other Releasees.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.498%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-top:1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.8pt;text-decoration:underline">Application for Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee understands and agrees that Employee does not have a right to future employment with the Company, and Employee hereby waives any right, or alleged right, of employment or re-employment with the Company.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Trade Secrets and Confidential Information&#47;Company Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee acknowledges that, separate from this Agreement, Employee remains under continuing obligations to the Company under the Confidentiality Agreement. Employee&#8217;s signature below constitutes Employee&#8217;s certification under penalty of perjury that Employee has returned all documents and other items provided to Employee by the Company, developed or obtained by Employee in connection with Employee&#8217;s employment with the Company, or otherwise belonging to the Company, including, but not limited to, all passwords to any software or other programs or data that Employee used in performing services for the Company.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to the &#8220;Protected Activity Not Prohibited&#8221; section below, Employee agrees to maintain in complete confidence the existence of this Agreement, the contents and terms of this Agreement, and the consideration for this Agreement (hereinafter collectively referred to as &#8220;Separation Information&#8221;), and Employee agrees that Employee will not publicize, directly or indirectly, any Separation Information. Except as required by law, and subject to the &#8220;Protected Activity Not Prohibited&#8221; section below, Employee may disclose Separation Information only to Employee&#8217;s immediate family members, the Court in any proceedings to enforce the terms of this Agreement, Employee&#8217;s counsel, and Employee&#8217;s accountant and any professional tax advisor to the extent that they need to know the Separation Information in order to provide advice on tax treatment or to prepare tax returns, and must prevent disclosure of any Separation Information to all other third parties. Employee acknowledges and agrees that the confidentiality of the Separation Information, as set forth herein, is of the essence. The Parties agree that if the Company proves that Employee breached this &#8220;Confidentiality&#8221; section, unless such breach constitutes a legal action by Employee challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, the Company shall be entitled to an award of its costs spent enforcing this provision, including all reasonable attorneys&#8217; fees associated with the enforcement action, without regard to whether the Company can establish actual damages from Employee&#8217;s breach. Any such individual breach or disclosure shall not excuse Employee from Employee&#8217;s obligations hereunder, nor permit Employee to make additional disclosures. Subject to the &#8220;Protected Activity Not Prohibited&#8221; section below, Employee warrants that Employee has not disclosed, orally or in writing, directly or indirectly, any of the Separation Information to any unauthorized party.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">No Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to the &#8220;Protected Activity Not Prohibited&#8221; section below, Employee agrees that Employee will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a subpoena or other court order to do so or upon </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">written request from an administrative agency or the legislature </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or as related directly to the ADEA waiver in this Agreement. Employee agrees both to immediately notify the Company upon receipt of any such subpoena or court order or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">written request from an administrative agency or the legislature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and to furnish, within three (3) business days of its receipt, a copy of such subpoena or other court order or </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">written request from an administrative agency or the legislature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to the &#8220;Protected Activity Not Prohibited&#8221; section below, if approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Employee shall state no more than that Employee cannot provide counsel or assistance. This &#8220;No Cooperation&#8221; provision does not extend to Employee&#8217;s cooperation and&#47;or assistance with Employee&#8217;s counsel in any effort to enforce the Third-Party Payor Agreement for Legal Services between Ehrlich &#38; Craig LLP and the Company entered into on October 21, 2024. Notwithstanding the foregoing, Employee agrees to cooperate with and provide assistance to the Company and its legal counsel in connection with any audit, inquiry, or investigation by any governmental or regulatory agency or with the defense or prosecution of any claim of any kind involving the Company, including any proceeding before any</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.498%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="padding-left:5pt"><font><br></font></div><div style="margin-top:1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">arbitral, administrative, judicial, legislative, or other body or agency, including testifying in any proceeding to the extent such claims, investigations or proceedings relate to services performed or required to be performed by Employee, pertinent knowledge possessed by Employee, or any act or omission by Employee. Employee further agrees to perform all acts and execute and deliver any documents that may be reasonably necessary to carry out the provisions of this Agreement.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Nondisparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to the &#8220;Protected Activity Not Prohibited&#8221; section below, Employee agrees to refrain from any disparagement, defamation, libel, or slander of any of the Releasees, and agrees to refrain from any tortious interference with the contracts and relationships of any of the Releasees. Employee shall direct any inquiries by potential future employers to the Company&#8217;s human resources department. The Company agrees that it will provide written instruction to the Company&#8217;s current executive officers and current members of its Board of Directors (in each case, as of the Effective Date) to refrain from any disparagement, defamation, libel, or slander of Employee.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.55pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Protected Activity Not Prohibited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee understands that nothing in this Agreement shall in any way limit or prohibit Employee from engaging in any &#8220;Protected Activity,&#8221; which means filing and&#47;or pursuing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (&#8220;Government Agencies&#8221;). Further, nothing in this Agreement shall in any way limit or prohibit Employee from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful (&#8220;Protected Information&#8221;). Additionally, nothing in this Agreement constitutes a waiver of any rights Employee may have under the Sarbanes-Oxley Act or Section 7 of the National Labor Relations Act (&#8220;NLRA&#8221;). For purposes of clarity, nothing in this Agreement shall be interpreted to impair or limit Employee&#8217;s participation in any legally protected activities, such as (i) forming, joining, or supporting labor unions, (ii) bargaining collectively through representatives of employees&#8217; choosing, (iii) discussing wages, benefits, or terms and conditions of employment, and (iv) discussing, or raising complaints about, working conditions for the purpose of mutual aid or protection of Employee or the Company&#8217;s other current or former employees, to the extent such activities are protected by Section 7 of the NLRA. When engaging in any of the protected conduct described in this section, Employee agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any Company confidential information&#59; provided, however, that such disclosures may be made to Government Agencies in connection with Protected Activity. For the sake of clarity, Company confidential information does not include Protected Information or information regarding working conditions, wages, benefits, or other terms and conditions of employment. Additionally, Employee understands that the protected conduct described herein does not include the disclosure of any Company attorney-client privileged communications or privileged attorney work product. Employee understands that nothing in the Confidentiality Agreement shall limit or prohibit Employee from engaging in any protected conduct set forth in this section. Finally, pursuant to the Defend Trade Secrets Act of 2016, Employee is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (a) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">solely </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the purpose of reporting or investigating a suspected violation of law, or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual&#8217;s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.498%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In addition to the rights provided in the &#8220;Attorneys&#8217; Fees&#8221; section below, Employee acknowledges and agrees that any material breach of this Agreement, unless such breach constitutes a legal action by Employee challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, or of any provision of the Confidentiality Agreement shall entitle the Company immediately to recover and&#47;or cease providing the consideration provided to Employee under this Agreement and to obtain damages, provided, however, that the Company shall not recover One Hundred Dollars ($100.00) of the consideration already paid pursuant to this Agreement, and such amount shall serve as full and complete consideration for the promises and obligations assumed by Employee under this Agreement and the Confidentiality Agreement.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">No Admission of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee understands and acknowledges that this Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Employee. No action taken by the Company hereto, either previously or in connection with this Agreement, shall be deemed or construed to be (a) an admission of the truth or falsity of any actual or potential claims or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Employee or to any third party.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:6.05pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Parties shall each bear their own costs, attorneys&#8217; fees, and other fees incurred in connection with the preparation of this Agreement.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. EXCEPT AS PROHIBITED BY LAW NOTWITHSTANDING THE APPLICATION OF THE FAA, THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, EMPLOYEE&#8217;S EMPLOYMENT WITH THE COMPANY OR THE TERMS THEREOF, OR ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION PURSUANT TO THE FEDERAL ARBITRATION ACT (9 U.S.C. &#167; 1, ET SEQ.) (THE &#8220;FAA&#8221;). THE FAA&#8217;S SUBSTANTIVE AND PROCEDURAL RULES SHALL GOVERN AND APPLY TO THIS ARBITRATION AGREEMENT WITH FULL FORCE AND EFFECT, AND ANY STATE COURT OF COMPETENT JURISDICTION MAY STAY PROCEEDINGS PENDING ARBITRATION OR COMPEL ARBITRATION IN THE SAME MANNER AS A FEDERAL COURT UNDER THE FAA. EMPLOYEE AGREES THAT, TO THE FULLEST EXTENT PERMITTED BY LAW, EMPLOYEE MAY BRING ANY SUCH ARBITRATION PROCEEDING ONLY IN EMPLOYEE&#8217;S INDIVIDUAL CAPACITY. ANY CLAIMS EMPLOYEE MAY BRING PURSUANT TO THE PRIVATE ATTORNEYS GENERAL ACT ON BEHALF OF THE LABOR AND WORKFORCE DEVELOPMENT AGENCY MUST BE ARBITRATED ONLY IN EMPLOYEE'S INDIVIDUAL CAPACITY WITHOUT ANY JOINDER OR REPRESENTATION OF ANY CALIFORNIA LABOR CODE VIOLATIONS THAT WERE OR COULD BE ASSERTED BY OR ON BEHALF OF ANY OTHER EMPLOYEES. ANY ARBITRATION WILL OCCUR IN THE COUNTY WHERE EMPLOYEE WAS EMPLOYED BY THE COMPANY AS OF THE SEPARATION DATE, BEFORE JAMS, PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES &#38; PROCEDURES, EXCEPT AS EXPRESSLY PROVIDED IN THIS SECTION. THE PARTIES AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO DECIDE ANY MOTIONS BROUGHT BY ANY PARTY TO THE ARBITRATION, INCLUDING MOTIONS FOR SUMMARY JUDGMENT AND&#47;OR ADJUDICATION, AND MOTIONS TO DISMISS AND DEMURRERS, APPLYING THE STANDARDS SET FORTH UNDER PRIMARY STATE&#8217;S RULES OF CIVIL PROCEDURE. THE PARTIES AGREE THAT THE ARBITRATOR SHALL ISSUE A WRITTEN DECISION ON THE MERITS. THE PARTIES ALSO AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE LAW, AND THAT THE ARBITRATOR MAY AWARD ATTORNEYS&#8217; FEES AND COSTS TO THE PREVAILING PARTY, WHERE PERMITTED BY APPLICABLE LAW. THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES. THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION. THE PARTIES AGREE THAT THE PREVAILING PARTY</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.498%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD. THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES&#59; PROVIDED, HOWEVER, THAT THE ARBITRATOR MAY AWARD ATTORNEYS&#8217; FEES AND COSTS TO THE PREVAILING PARTY, EXCEPT AS PROHIBITED BY LAW. THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY. NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE. SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS PARAGRAPH CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT SHALL GOVERN.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Tax Consequences</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company makes no representations or warranties with respect to the tax consequences of the payments and any other consideration provided to Employee or made on Employee&#8217;s behalf under the terms of this Agreement. Employee agrees and understands that Employee is responsible for payment, if any, of local, state, and&#47;or federal taxes on the payments and any other consideration provided hereunder by the Company and any penalties or assessments thereon. Employee further agrees to indemnify and hold the Releasees harmless from any claims, demands, deficiencies, penalties, interest, assessments, executions, judgments, or recoveries by any government agency against the Company for any amounts claimed due on account of (a) Employee&#8217;s failure to pay or delayed payment of, federal or state taxes, or (b) damages sustained by the Company by reason of any such claims, including attorneys&#8217; fees and costs.</font></div><div style="margin-top:12.1pt;padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Employee represents and warrants that Employee has the capacity to act on Employee&#8217;s own behalf and on behalf of all who might claim through Employee to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Section 409A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> It is intended that this Agreement comply with, or be exempt from, Code Section 409A and the final regulations and official guidance thereunder (&#8220;Section 409A&#8221;) and any ambiguities herein will be interpreted to so comply and&#47;or be exempt from Section 409A. Each payment and benefit to be paid or provided under this Agreement is intended to constitute a series of separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. Payments under this Agreement will be made no later than March 15, 2025. The Company and Employee will work together in good faith to consider either (i) amendments to this Agreement&#59; or (ii) revisions to this Agreement with respect to the payment of any awards, which are necessary or appropriate to avoid imposition of any additional tax or income recognition prior to the actual payment to Employee under Section 409A. In no event will the Releasees reimburse Employee for any taxes that may be imposed on Employee as a result of Section 409A.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.05pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.498%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except with regard to a legal action challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, in the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys&#8217; fees incurred in connection with such an action.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement represents the entire agreement and understanding between the Company and Employee concerning the subject matter of this Agreement and Employee&#8217;s employment with and separation from the Company and the events leading thereto and associated therewith, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter of this Agreement and Employee&#8217;s relationship with the Company, including any Change in Control and Severance Agreement by and between Employee and the Company, with the exception of the Confidentiality Agreement, the applicable Equity Award Agreements (if any), and the Company&#8217;s Compensation Recovery Policy, as most recently amended on October 24, 2023, except as otherwise modified or superseded herein.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">No Oral Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement may only be amended in a writing signed by Employee and the Company&#8217;s Chief Executive Officer.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement shall be governed by the laws of the State of CA (the &#8220;Primary State&#8221;), without regard for choice-of-law provisions. Employee consents to personal and exclusive jurisdiction and venue in the Primary State.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:6.05pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">27.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee understands that this Agreement shall be null and void if not executed by Employee within twenty-one (21) days. Each Party has seven (7) days after that Party signs this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after Employee signed this Agreement, so long as it has been signed by the Parties and has not been revoked by either Party before that date (the &#8220;Effective Date&#8221;).</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">28.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement may be executed in counterparts and by facsimile, and each counterpart and facsimile shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.</font></div><div style="margin-top:12.1pt;padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">The remainder of this page is intentionally left blank&#59; signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.498%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">29.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.3pt;text-decoration:underline">Voluntary Execution of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Employee understands and agrees that Employee executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of Employee&#8217;s claims against the Company and any of the other Releasees. Employee acknowledges that&#58;</font></div><div style="margin-top:12.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Employee has read this Agreement&#59;</font></div><div style="margin-top:11.95pt;padding-left:113pt;padding-right:5.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Employee has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of Employee&#8217;s own choice or has elected not to retain legal counsel&#59;</font></div><div style="margin-top:12pt;padding-left:113pt;padding-right:6.05pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Employee understands the terms and consequences of this Agreement and of the releases it contains&#59;</font></div><div style="margin-top:12.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Employee is fully aware of the legal and binding effect of this Agreement&#59; and</font></div><div style="margin-top:11.95pt;padding-left:113pt;padding-right:5.85pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Employee has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.</font></div><div style="margin-top:11.3pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:2.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.941%"><tr><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">JEFF EIDEL, an individual</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12&#47;5&#47;2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Jeff Eidel</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jeff Eidel</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PACIFIC BIOSCIENCES OF CALIFORNIA, INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12&#47;5&#47;2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Natalie Welch</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Natalie Welch</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief People Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.498%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-right:-2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>pacb-20241111.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:658ad983-a5a7-4729-8248-e8ac8f640e7c,g:ae8b7241-1ef8-4b94-8ae5-be4fdafcd5ca-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pacb="http://www.pacificbiosciences.com/20241111" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.pacificbiosciences.com/20241111">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pacb-20241111_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pacb-20241111_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.pacificbiosciences.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>pacb-20241111_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:658ad983-a5a7-4729-8248-e8ac8f640e7c,g:ae8b7241-1ef8-4b94-8ae5-be4fdafcd5ca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4b5d444d-781d-47db-a3e9-edd1e2e60008_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_80646acc-1147-4d2d-b7e1-555b680bdf72_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_59b36f9f-aca3-4c7c-bda8-c2b635045067_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_1aee0efb-674b-4437-a34b-d05ec4f173d6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentDescription_bb979d9b-008c-473c-ad5f-0b6361f54e55_terseLabel_en-US" xlink:label="lab_dei_AmendmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Description</link:label>
    <link:label id="lab_dei_AmendmentDescription_label_en-US" xlink:label="lab_dei_AmendmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentDescription" xlink:to="lab_dei_AmendmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_93a925f4-bb0a-478e-95a1-ab753d2a0a33_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_e37babc7-bc1a-4a1e-9b0d-d5683226f4e9_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1fb7ec21-ed3a-425d-b881-d22df6cea4d3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f75a930d-6a3c-4b68-b334-f1fd700a1435_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_35cb28cb-b136-467b-aac1-604a77d67ae5_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2e0187d8-48cd-4ec7-af63-88c63e223c11_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c9938238-0e0a-458e-abc8-4731281c18fa_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_03576e7a-4a76-4168-96d6-e973efbe1031_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a8559a62-7194-4275-aa0f-57b3c011c86d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7a6bc034-bfb5-428e-bb44-f7517b3214ff_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_01eacffd-b172-473d-b299-742699ab2104_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_69c23817-3143-4677-a789-3aeeb06d2387_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d1af02a3-ee82-41c0-8a66-fbbaee6070b9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_64da0a3e-af04-47e0-9cc1-6045921dfba9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_99d0f70e-ee6e-4458-abc6-c1a2d881ea50_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_533709d5-fc5a-40cb-91f1-ffafdc3e8198_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ce708ff3-393d-471b-9bd5-d546af3a6a39_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5026a7e9-b167-4b5b-861d-cb516be088cf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>pacb-20241111_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:658ad983-a5a7-4729-8248-e8ac8f640e7c,g:ae8b7241-1ef8-4b94-8ae5-be4fdafcd5ca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pacificbiosciences.com/role/CoverPage" xlink:type="simple" xlink:href="pacb-20241111.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.pacificbiosciences.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5eacd25b-52f7-4dc1-9f64-e5e792c406dd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_DocumentType_5eacd25b-52f7-4dc1-9f64-e5e792c406dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3985fd7e-351f-471f-934f-04876e7f0f80" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_DocumentPeriodEndDate_3985fd7e-351f-471f-934f-04876e7f0f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b4cdb23c-c30d-48a1-9ad7-27b60885868a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityRegistrantName_b4cdb23c-c30d-48a1-9ad7-27b60885868a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_dd356732-b2b8-4751-9c5f-b125a876d589" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityIncorporationStateCountryCode_dd356732-b2b8-4751-9c5f-b125a876d589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a73af231-fc0e-41f8-a137-a08008966695" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityFileNumber_a73af231-fc0e-41f8-a137-a08008966695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_716ccc77-9041-43aa-bbd0-d06939fe25ec" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityTaxIdentificationNumber_716ccc77-9041-43aa-bbd0-d06939fe25ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e0003c4f-7d54-42c3-9b81-70cb4b1ac30b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityAddressAddressLine1_e0003c4f-7d54-42c3-9b81-70cb4b1ac30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3dab5404-3fa1-48d0-b25a-6cdac9377914" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityAddressCityOrTown_3dab5404-3fa1-48d0-b25a-6cdac9377914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4ae5a658-b641-4fb0-b381-4766bc4c27bb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityAddressStateOrProvince_4ae5a658-b641-4fb0-b381-4766bc4c27bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c4cd60d5-d723-409b-a3b2-bfd4777a2a0a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityAddressPostalZipCode_c4cd60d5-d723-409b-a3b2-bfd4777a2a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1b191e29-4d5a-435b-95dc-cd5b0a9d6421" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_CityAreaCode_1b191e29-4d5a-435b-95dc-cd5b0a9d6421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_9d8973c2-4ad5-4abc-bc32-b24bcdef782e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_LocalPhoneNumber_9d8973c2-4ad5-4abc-bc32-b24bcdef782e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5f59c8d7-555e-4898-a334-815b964fb799" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_WrittenCommunications_5f59c8d7-555e-4898-a334-815b964fb799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_efcc39ec-9f42-4b0b-a6d5-c83f5ab33412" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_SolicitingMaterial_efcc39ec-9f42-4b0b-a6d5-c83f5ab33412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f8366652-05fc-48de-bd76-90cea02c5e70" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_PreCommencementTenderOffer_f8366652-05fc-48de-bd76-90cea02c5e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6cde5544-6102-4ef2-82af-386b63eaa079" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6cde5544-6102-4ef2-82af-386b63eaa079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_38b2726c-f8b5-4205-8735-7752b3a1c99b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_Security12bTitle_38b2726c-f8b5-4205-8735-7752b3a1c99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3dc88d37-d59c-4118-ab7b-3c85a8d3c062" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_TradingSymbol_3dc88d37-d59c-4118-ab7b-3c85a8d3c062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5fa1a4c6-b34c-4194-9b6c-a444701ad462" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_SecurityExchangeName_5fa1a4c6-b34c-4194-9b6c-a444701ad462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8284ac71-bda3-462a-aec3-18c75c68c5ef" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityEmergingGrowthCompany_8284ac71-bda3-462a-aec3-18c75c68c5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_adb4e294-b557-491a-8de2-31ae8b8e8426" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_EntityCentralIndexKey_adb4e294-b557-491a-8de2-31ae8b8e8426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9557a1c4-289c-4d74-8e39-da6b9626f420" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_AmendmentFlag_9557a1c4-289c-4d74-8e39-da6b9626f420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentDescription_975a3e44-559f-4fa6-993f-389a899195bc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2f3bc7ec-5e5a-4481-abff-929a699bf688" xlink:to="loc_dei_AmendmentDescription_975a3e44-559f-4fa6-993f-389a899195bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !@ : # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4<XXQ59[
MF.!=TK!%]S4V<8'>OBS_ (*C$M\'_"Q_A.O+_P"D\M;4:?M:G(>AEN#_ +0Q
M=+"\W+S'V;]OMO\ GXC_ .^J/M]M_P _$?\ WU7X!8'K1@>M>U_9;_G/U#_B
M'W_45_Y+_P#;'[^_;[;_ )^(_P#OJC[?;?\ /Q'_ -]5^ 6!ZT8'K1_9;_G#
M_B'W_45_Y+_]L?OY'?PN=HE1F] :<WS'AOTK\"+6XFM;A)[=W@E3[KQ/M9:]
MH^&'[8'Q2^%MW&UMXGN=9L5/S:=K+-=1,OU;YE_X"RUE++)+X)'!BN <5"/-
MAZO/_P"2G[*Y/89I2?EZ5\[_ +-O[7_AC]H*$::<Z'XK2+=+I-Q+S)Q\SPM_
M&G_CRU]#JQP>>E>14ISI2Y9GYOBL)7P55T,1'ED24445F<P4444 %%%% !11
M10 4444 %%%% !1110 4444 1X^:FLP1"34GO7(_%<X^&WBGWTNZ_P#1354?
M>=BX1YYQB=+]N@_Y[I^='VZ#_GNGYU^,]%?2_P!B/^<_<O\ B%S_ .@O_P E
M_P#MC]F/MT'_ #W3\Z/MT'_/=/SK\9Z*/[$?\X?\0N?_ $%_^2__ &Q^S(OK
M?O,A_&GK,DH^1U;_ '37XQUHZ1XBU30)5DTO4KS375MRFVF:-C_WS2_L1_SF
M<_#&?)[F*_\ )?\ [8_8T]CGZFFX4@Y^Z:_/SX1_ML^(_#%W!9^,/^)_I.=C
M72*J747X_=D_X%_WU7W3X7\5Z9XPT"VUG1[Z.^L+I0\5Q$.&&:\;$82KA7:9
M^8YWP]C\AFHXN'NR^U]EF]6/XD\5:7X/T:ZU;6;R+3]/MEWRSS-A5'O6N#MP
M#VKX>_X*"^);TZUX<T%)&33_ "6O)%1O];)N"IN_W=K?]]5.&H_6:OLC+(<J
M>=YC2P*ER\YZ-/\ MZ?#R"[,4=GK=Q&C;/M$=O'L;_OJ3=^E>T?#WXG^'/BA
MHQU/P_J"7MOG;(HR)(V_NNO\)K\DZ]__ &(/$-[I7QRL--AD9;+5;>>.YA_@
M;;$\JO\ [VY3_P!]O7OXG*Z5.E.=+[)^M9_P#@<'E]7%8&<N:E'F]X_22BBB
MOE3\'"BBB@"+=Z<TAE*_P_K7!^)_CAX#\(R20:SXJTZPN$'S6[3;I1_P!?FK
MD)/VR/A(&93XH+E3@[=/NO\ XU6T:-27PP/3H95F&)CSX>A.7I&1[-'DFK*C
MCFO*_#_[2?PV\1NJ6?B_3DD;I'=.;=C^$@6O2H;F.[@66&42Q.,K(IW*U3.$
MH_$<5;"U\++DQ$)1?]XN4445F8A1110!&.E?&'_!4;_DC_A3_L/+_P"D\M?9
MXZ5\8?\ !4;_ )(_X4_[#R_^D\M=N#_CP/I.&O\ D;X?_$?F4>378?#_ .%_
MB_XH7EW:^$]%N-9GM466=("HVJW^]7(N-CD>E?;_ /P2VX\?>-O^O&#'_?9K
MZC$U)4J4I1/Z SO'5<LP%7%TOBB>!_\ #'GQG_Z$/4_SB_\ BZ/^&//C/_T(
M>I_G%_\ %U^S^#ZT8/K7A?VI5_E1^3_Z_9C_ ,^H?^3?_)'X?^,O@%\1?A_I
MG]H:]X/U2PT]1\UV81)$G^^R?<_X%7GS* H85^_,D"3QM#, ZL,,C#K7Y:?M
M[_L^:7\(_&^F^(?#T"66@Z^KJUG"FR*WN4V[]O\ =5E96V^SUW87'^TERS/J
M.'^+WF=?ZKBH\LI?#8^8/#^NW_AG5[/5=,NI+'4;&99X)X_O1LOW:_9#]E[X
MVVWQ[^%.GZ^0D6J1$VFI6Z<^5<+][\&7:P]FK\7U^1\5]N?\$O\ Q?-9?$/Q
M5X59O]&O;!+]5_VXFV?^@RC_ +YJ\?0YJ?-_*=7&F6PQ67_6U\=(_2C@BDHK
M$\5^+M(\$:-<ZMKFI6^EZ;;+NENKJ0(B#WKY<_ HQE*7+$VUQGK37;;_ !8_
M"OAKXE_\%.="TN6>R\#^';C7)4;8NH:A+]GMW']Y$QO;_@6RO%+W_@I7\7+B
M;=%:>'+*/^Y'8R,?_'I6KT(8"O/H?7X;A'-\3'F]ER_XC]3(P4// J1CM (.
M*_-#PG_P4]\<V-W%_P ))X9T?5+,###3B]K+^;,Z_P#CM?6?P1_;'\ _&_;8
MV%])HVOLO_()U'"RO[QM]V3\#N_V:SJX6O2^*)PX_AS,\NASUJ7N]XZGO2HR
MCY7P/I2&//5L'Z5\-#_@J?X>P!_P@>I$_P#7_%_\371_#;_@HGH_Q*\?:'X6
MA\'7]A/JMRMLMS+>(ZQ$^JA:)86O&/-RCJ\-YK1I3K3H>['_  GV51117$?.
M#,<<"FD$]L_C6=KFLV/A_3IK_4KR&QL8%WRW%U(L44:^K,W2OD?XH?\ !23P
M5X2N;BQ\):9<^,+N/C[2DGV>U#>F]EW-^"X_VJVI4:E7X(GH8/+L7F$^3"T^
M8^R\D]J,D=J_+?5O^"F?Q0OIG%AIGA[382WRYM9)7'_ VDV_^.U%IW_!3#XI
MV<X^W6'AW4(OXE^QRQ-_P%EE_I7=_9U<^I_U*SCDY^2/_@2/U+"X_AQ^-.Y'
M:OBCX<_\%,O">NWD5EXQT&Z\+2NVT7D$WVJV'NV$5U_[Y:OL#PQXFTKQ;H]M
MJFBW]OJ6G7"[HKFUE\V-Q[,*X:M&I2^.)\QC<LQF6SY,52Y34KE/BM_R33Q9
M_P!@JY_]%-75URGQ6_Y)IXL_[!5S_P"BFJ(?%$X:'\6/^(_(VK.FZ9=:QJ5M
MI]G$9[N[D6"&)?O,S-M5:K5UWP?&?BSX,'_49M/_ $>M?I%67)#G/[=QU:>%
MPU2O#[$&=!_PS-\4?^A,U#\T_P#BZ=_PS-\4?^A,OOS3_P"+K]3\'UHP?6OD
M?[9K_P I_/7_ !$O-?\ GU#_ ,F_^2/RL_X9H^)XZ^#K_P#%D_\ BZX?Q#X9
MU7PG?M8ZSIUUIEV.1'<QLK&OV'0@G*C"^N:\9_:A^&NG>/OA3K4TUNC:EIMK
M+>V<Y'SHZ*&90>VY5V_C750S>4ZG+5B>EEGB3B:F)C3QM*/)+^4_,JOI#]BG
MXL/X3\>+X6OI3_9&L$F-7ZQW.#M;_@?W?^^*^;ZV?!5_)I?C'0;R+F2WU""1
M?]Y95:O>Q-.-6E*,C]BSW+J>:9;5PM3?E_$_88C/(KYX_:V^ 5]\7]!L[_1%
M5]=TDN8X';:)XFQN7_>^7Y:^A48<#UKS7XZ?&6W^"OA.UURXT^748Y[H6WE0
MN%(RK-NY'^S7P>&G5A5C[+XC^1LGKXO#X^E5P'\6_NGYGW?PY\665]]DF\-:
MNMWNV^6+*7=_Z#7US^QU^SCJ_A36W\8^*+,V%P(&@L;"7F1-WWI6_N';\NW_
M &FJ3_AX?H__ $)NH?\ @6G_ ,17JWP&_:+L?CC<:REIHT^E#35A+F:99-WF
M;\=/]RO>Q=?&3H6E#EB?K7$N;<25\KE#$X7V5+[<N8]I(&!G\*.2>G%(1SFO
M+_CI\8[#X+^"Y]6F"W.H2YBLK7=@RR__ !*@[F]A7S<8RG+EB?BF'P]7%5H4
M*$>:4A/C3\>/#'P7TD2:I*;G59E_T73+=_WLI]?]E?\ :KX)^*/[3'CCXIS/
M%<ZG)I>D_P &G6):)=O^VX^9O^!5P/BWQ;JWCC7KG6M:NC>ZC<-NDD;H!_<3
M^XE8U?;83+Z6'CS3]Z1_4'#O!F#R>G&MB8>UJ_\ I/\ A"BBBO4/T<*['X?_
M !>\6_#&\270M7E@@W;FLYFW02?[T?W17'45,H0G#DF<N*PN'QE+V.)ASP/T
M7^ '[6>C?%62'1M75=#\1[?DB=LQ7/\ UR;^]_L_^A5]"L-VXXZ_K7XRPS-#
M*DL3,DJ-O5T?[E?H1^R7^T6WQ+T7_A&]>G!\2V$899F;_C\AY^?_ 'UX#?\
M?7>OE<PP'L?WM+X3^>>,."XY7#Z_@/X7VH_R?_:GTS1117SQ^1$8Z5\8?\%1
MO^2/^%/^P\O_ *3RU]GCI7QA_P %1O\ DC_A3_L/+_Z3RUVX/^/ ^DX:_P"1
MOA_\1^9J_.&S[5]O?\$LLKX\\;XY_P! @_\ 1AKXA?@L!TXKZ5_8E^/WAC]G
M[Q-XBO\ Q1]L\C4K2*" 6</F?,K%O[U?28N,IT)1@?NG$M"KB,IJTJ4>:7_V
MQ^MF?>C/O7R?_P /*OA%_=U[_P  1_\ %4?\/*OA%_=U[_P!'_Q5?,?5:_\
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M79'<KZ'^ZZ\;EIT<;3Q"Y8EY3Q/@<XG[*E[L_P"61Y4O45ZO^RE_R<=\/?\
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MU2A_.C]B_P#A)]+_ .@E9_\ ?]:/^$GTO_H)6?\ W_6OQTHKYK^Q%_.?BO\
MQ#!?]!?_ )+_ /;'[#KXCTR+IJ=FP]!,M?-?[5W[1WA[3O!&I^%=#U&WU;6-
M3C>TF^S2"2.WC;[Y=ON[MN1MSGFO@RBMZ.4QIRYYS/3RWPWPN"Q,*^(Q'/R_
M9Y>4*]&_9\\%W'COXO>&]/AC9HXKH7MPY_ACB;<W_H.S_@=><U^A_P"QS\(]
M'\%^"D\107UMJVKZNBM+=6QWI"H_Y8IS_P!]?[7^[7?F&)^KT#ZWB_.8Y/E<
MW]N?N1/I ]*^8_V_O^2/Z7_V%XO_ $7)7TX>E?,?[?W_ "1_2_\ L+Q?^BY*
M^/P?^\P/YMX9_P"1UA/\:/S\K[(_X)T_\?WCS_<LO_;BOC>OLC_@G3_Q_>//
M]RR_]N*^LS/_ '61_1G'/_(@K_\ ;O\ Z5$^TRZ\'\J_,S]K'XG/\1?BS?Q0
MN5TK1F:QMHR_RLZL/-;_ ($W_CJ+7Z&?$OQ#_P (E\/_ !!KB;?,L+&:X3=Z
MJI(K\C9IFFE>65M[NVYG?^*O+R>AS2E5/S3PURV-;$U<?/['NQ]9#:***^I/
MZ'"BBB@ HHHH *W? ?C"\\ ^+=,U_3F_TFRF60H'YE3^-6_V67Y:PJ*F4>>/
M),PJTH8JC.C6^"9^Q'AOQ!:>*] T_5K!_,L[Z!+F%O5&7<IK7(P<U\^_L3>(
MV\0?!&P@E(=]-N9K//\ L[BZ?^.R"O?=]?G5:E[.K*!_%&8X5Y?C:N%?V)./
MW$HZ5\8?\%1O^2/^%/\ L/+_ .D\M?9XZ5\8?\%1O^2/^%/^P\O_ *3RUO@_
MX\#U>&O^1OA_\1^98.RC<1SFC;AL&O:OV:?V<+C]I/7-9TZVUY-";3+=9V>2
MU^T>9N;;_?7T-?72E"E'GF?TCC,92P-"6(Q$N6$3Q7'M1CVK[R_X=4:K_P!%
M%M/_  4M_P#':/\ AU1JO_11;3_P4M_\=KC_ +0PW\Y\Y_K;DO\ T$?^2R_^
M1/@_:/[_ .E&Y!U3/XU^@&E_\$K8=L3:E\0Y6_YZ1VFE!2?^!M+_ .RU[;\-
M/V$_A5\-IX[I])G\1ZA&=R76LR^:%^D:[4_\=J)9C1C\!YN*XVRJC']U)S_K
M^\?%W[*/['>M?&?5++7?$-M)I7@:&02O)+Q)J&.BQ#^YD?,__?-?JIIVEVVC
M:9!8V-NEO:6T:Q001#:D:+]U5%7(K>.% B+M1>BT%3L;+8S[5\_B,1+$2O(_
M'<YSK$YS7]K6^&/PQ/Q1_::\1S>*_CYX^U":3S=NK36T;#_GG$WE)_XZBUY>
MW%=C\8X9+3XM>.8)EVR)KEXK+_V\/7'#YB*^OI:1@?TG@(1A@Z4(?RQ/VC_9
MA^%=K\)?@QX>T2&!8KV2V2[O6*X:2YD7=(6^F=O^ZJU[ .,^U9^C:Q;ZYI5C
MJ%FWF6UW"EQ$W]Y&7<OZ&M$L #7P\I2G+FD?RIB*E2O6E5J_%(;]X#WKQ?\
M:P^%$'Q9^"'B/3I(5DO[*VDO["0+\ZSQKN&WW8!D_P"!5[4"  :P?&6KVWA_
MPIK>H72QO:6=E/<RI*-R,J(S-N]N**<I1ES1##5:F'K0JTG[T3\&EZBO5_V4
MO^3COA[_ -A:.O*%ZBO5_P!E+_DX[X>_]A:.OM*_\*9_5&9_[AB/\$O_ $D_
M:O.<>U?B!^T'XE?QA\;?'6JN^]9=6F2)QWB1MD7_ (XBU^WT@PAK\)/B3$]M
M\0?%44JNDRZK<JR.OS*WG-7A97\4C\EX C'ZU7G_ '3GK<R %$7<\F-J5^UO
M[//PKM/@[\)?#WARW@$5Q! LEZ_\4MR_S2NQ_P!XG_@*K7XJV$J6U]#*WW$E
M1FK][=.O(KZRBN86WQ2HLB-ZJ>E;9G*7+&)W^(-:I&GAZ7V?>-&BBBOGS\<.
M-^(OP^TGXH^#=3\-:Y 9M/U& Q2E3\R=U=?1E8*R^ZUYIX%_8N^$GP[:*:V\
M)0ZM>1C_ (^]78W+_P#?+?(/^ J*]W QU&*4J&'M6D:LXQY8R.FGC,31INE2
MJRC$JV5G#86R06T4=O!&NU8HUVJM<]\5O^2:>*_^P5<_^BFKJATKE?BM_P D
MT\5_]@JY_P#134X_$94/XL?\1^1E6=+TJZUK4[33[&$SWUW,L$,:]&D9MJK5
M:NO^#PS\6O!@]=9M!_Y'6OT:<^2'.?V[CJT\+AJU>'V('5?\,H_%?_H3;C_P
M*M__ (NC_AE'XK_]";<?^!5O_P#%U^HNT>GZT;1Z?K7R/]LU_P"4_G?_ (B7
MFO\ SZI_^3?_ "1^70_92^*S=/!UQ_X%V_\ \77,^,_@YXT^'UO]HU[P[=Z?
M;?Q3D;XA]63Y:_6ME)Z'%4M2TNUUBSEMKR".XMY4V212KN5U/\++5PSFKS>]
M$UI>)F9*I^]I0Y?^WO\ Y(_&ZO4?@+\<=1^#7BN&<.]UH-RRK?V![K_?3_:6
MJ?[0/PYB^%OQ5UC0;3=_9Z,D]HK-@+'*F[;]%^[_ ,!KSJOI?W6(I?W9'[M*
M.#S_ "WWX<U*K$_9#3-4M=7L+:^M)UGMKF-98I$Y5U;[K5\Y_M_C_BT&F?\
M87B_]%R5L_L5^*;CQ'\$+"&X+.VDW$E@KOW1<,GY+(%_X#6+^WVV[X/:<?\
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MF>W3_OF)U6F67[#_ ,$].N1-%X!MF=>BSWMS*G_?#2E?TKTO[4I_R'V_^ON
MY?X4_P#R7_Y(_([POX1U?QIJ\>F:#I-WK%_)RL%G"TC8K[Y_9@_X)\?\(_>6
MWBCXF107&H1LLEKX?C998HF_O3N/E9_]E?E_WJ^S_"7@K0/!6GBT\/Z-8Z+:
M+TAL;=8D_):Z 8V]/PKSZ^8SJ>[#W3X[-N,\3CX>RPT?90_\F'^U<A\5UW?#
M?Q2?32KK_P!%-77 X:H)H$N8GBD57C8;65AUKRHRY9'P$)<DXR/QFHK]?_\
MA /#G_0!TS_P$C_^)H_X0'P[_P! '3/_  $C_P#B:^G_ +;C_(?NW_$3X?\
M0)_Y-_\ :GY 45^O_P#P@/AW_H Z9_X"1_\ Q-'_  @/AW_H Z9_X"1__$T_
M[;C_ "!_Q$^'_0)_Y-_]J?D!3TA:=]L2L[M_ BU^O@\ >'1_S =,_P# 2/\
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3QV/Q.95WB,5/FFQU%%%8G ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45011918891264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Nov. 11, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 11,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Pacific Biosciences of California, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1590339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1305 O&#8217;Brien Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Menlo Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">521-8000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PACB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001299130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ 78:-69>*NQS     $P(   L
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M<F]P<R]A<' N>&UL4$L! A0#%     @ 78:-68W.FR#O    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 78:-
M69E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !=AHU9:18=%<,$  "[$0  &
M@($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 78:-
M69^@&_"Q @  X@P   T              ( !!PT  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " !=AHU9EXJ[',     3 @  "P              @ 'C#P
M7W)E;',O+G)E;'-02P$"% ,4    " !=AHU9&445]3<!   G @  #P
M        @ ',$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 78:-620>
MFZ*M    ^ $  !H              ( !,!(  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ 78:-6660>9(9 0  SP,  !,
M     ( !%1,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&7Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="pacb-20241111.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pacificbiosciences.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K/A" isOnlyDei="true" original="pacb-20241111.htm">pacb-20241111.htm</File>
    <File>pacb-20241111.xsd</File>
    <File>pacb-20241111_lab.xml</File>
    <File>pacb-20241111_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "pacb-20241111.htm": {
   "nsprefix": "pacb",
   "nsuri": "http://www.pacificbiosciences.com/20241111",
   "dts": {
    "inline": {
     "local": [
      "pacb-20241111.htm"
     ]
    },
    "schema": {
     "local": [
      "pacb-20241111.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "pacb-20241111_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pacb-20241111_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.pacificbiosciences.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pacb-20241111.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pacb-20241111.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Description",
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.pacificbiosciences.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001299130-24-000198-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001299130-24-000198-xbrl.zip
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MH#Q%.OQ)$6-208T9F7R+91"!4@^/WN+"T!^[.F%!0T7=\TIF Z'QX=CU^.Y
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M"ME!:IP&&',HK=\L<R=F2B&*'79M+,,:F[SXJ(HD5&B9&HK<?J8J8=)<AVH
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M<&X\1#".=RW8X4M];*^:[^@<7XA/W=X_>/<N6A];5]T;VMDFO'W^65S?PA+
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MXC@PX5RLGDY4(IBV$FAF#?85FY):L5S!4H)!15A^L#ZVGBYS$S[F*LV7@5I
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MKDO!6S4E"[YA-.1-50VO2VYM<P%?VD%Z7\FD)?,?^NC_!:C]_U!+ P04
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M$+DN'!$'5,0*A'J82Z"*L8QC6U#[!(X,Z(-DT-*TA[*W2P[#.-:H&X1N'IW
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M3:3I'U-M&^A]/K73P'<OY(+>?1(Z6*XVZPB;RE= JL*((B ET2,0Y"$@-$F
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MH[W_ 5!+ 0(4 Q0    ( %V&C5ETD-QF03<  +Q% 0 >              "
M 0    !E>&AI8FET,3 Q+7-E<&%R871I;VYA9W)E92YH=&U02P$"% ,4
M" !=AHU9X]*;1O,1   4:P  $0              @ %]-P  <&%C8BTR,#(T
M,3$Q,2YH=&U02P$"% ,4    " !=AHU9P9VU8F@"   D!P  $0
M    @ &?20  <&%C8BTR,#(T,3$Q,2YX<V102P$"% ,4    " !=AHU9LJQ"
M<F$*  #65P  %0              @ $V3   <&%C8BTR,#(T,3$Q,5]L86(N
M>&UL4$L! A0#%     @ 78:-6=1A9UOE!@  "3,  !4              ( !
MRE8  '!A8V(M,C R-#$Q,3%?<')E+GAM;%!+!08     !0 % % !  #B70
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>pacb-20241111_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pacb-20241111.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001299130</identifier>
        </entity>
        <period>
            <startDate>2024-11-11</startDate>
            <endDate>2024-11-11</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001299130</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">true</dei:AmendmentFlag>
    <dei:AmendmentDescription contextRef="c-1" id="f-23">DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.</dei:AmendmentDescription>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K/A</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-11-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Pacific Biosciences of California, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-34899</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">16-1590339</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1305 O&#x2019;Brien Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Menlo Park</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">94025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">521-8000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">PACB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
